Notably, TOX has also been described as an extracellular ligand mediating inflammatory activation through the TOX–RAGE (Receptor for advanced glycation end-products) axis in severe pulmonary disease, highlighting context-dependent roles of this factor (24). This evidence concerns the gene TOX and lung disorder.